Serum fibroblast growth factor 21 levels is associated with lower extremity atherosclerotic disease in Chinese female diabetic patients

BACKGROUND: Fibroblast growth factor 21 (FGF21) is an emerging metabolic regulator associated with glucose and lipid metabolism, and it is still unclear whether FGF21 is related to atherosclerosis. Here, we explored the potential link between FGF21 and lower extremity atherosclerotic disease (LEAD)...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xiaoyan, Hu, Yanyun, Zeng, Hui, Li, Lianxi, Zhao, Jungong, Zhao, Jun, Liu, Fang, Bao, Yuqian, Jia, Weiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359481/
https://www.ncbi.nlm.nih.gov/pubmed/25850006
http://dx.doi.org/10.1186/s12933-015-0190-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359481/
https://www.ncbi.nlm.nih.gov/pubmed/25850006
http://dx.doi.org/10.1186/s12933-015-0190-7

Ejemplares similares